MedTrace Logo

Comparison Amongst Scleral, Corneal and Amniotic Membrane Grafts to Restore Scleral Thinning

NCT00801073 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2008-12-03

No results posted yet for this study

Summary

The purpose of this study is to evaluate the use of preserved scleral, corneal and amniotic membrane graft for the surgical repair of scleral thinning of different sizes in patients underwent surgery of pterygium with associated beta therapy .

Conditions

  • Scleral Thinning

Interventions

PROCEDURE

Human Amniotic Membrane Transplantation

Human Amniotic Membrane Transplantation for The Treatment of Ocular Surface Disease

Sponsors & Collaborators

  • Federal University of São Paulo

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-02-28
Primary Completion
2005-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00801073 on ClinicalTrials.gov